Chaoju Eye Care Holdings Limited (2219.HK)

HKD 2.49

(1.22%)

Market Cap (In HKD)

1.72 Billion

Revenue (In HKD)

1.36 Billion

Net Income (In HKD)

228.91 Million

Avg. Volume

1.3 Million

Currency
HKD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
2.71-4.57
PE
8.3
EPS
0.3
Beta Value
0.456
ISIN
KYG2047K1094
CUSIP
-
CIK
-
Shares
690776935.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Mr. Bozhou Zhang
Employee Count
-
Website
https://www.chaojueye.com
Ipo Date
2021-07-07
Details
Chaoju Eye Care Holdings Limited owns and operates a network of ophthalmic hospitals and optical centers in China. Its consumer ophthalmic services include treatments and prevention for various ophthalmic disorders, such as refractive and presbyopia correction, and myopia control, as well as optical products and services. The company also provides basic ophthalmic services, including cataract, glaucoma, ocular fundus diseases, ocular muscle diseases, refraction errors, pediatric ophthalmology, ocular surface diseases, lacrimal diseases, orbital diseases, oculoplastic, and ocular trauma. As of December 31, 2021, it operated a network of 17 ophthalmic hospitals, 24 optical centers, and 2 clinics in Zhejiang, Jiangsu, Shanxi, and Hebei provinces, as well as in Inner Mongolia. The company was founded in 1988 and is headquartered in Beijing, China.